Neubase Therapeutics Inc. buy krebskrebs
Start price
21.03.22
/
50%
€31.80
Target price
21.03.23
€50.00
Performance (%)
-89.56%
End price
22.03.23
€3.32
Summary
This prediction ended on 22.03.23 with a price of €3.32. The BUY prediction by krebskrebs for Neubase Therapeutics Inc. performed very badly with a performance of -89.56%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Neubase Therapeutics Inc. | -10.791% | -10.791% | -89.552% |
iShares Core DAX® | 2.749% | 4.620% | 17.121% |
iShares Nasdaq 100 | 0.470% | -0.331% | 37.776% |
iShares Nikkei 225® | -2.930% | -5.556% | 12.185% |
iShares S&P 500 | 0.679% | 0.631% | 28.996% |
Comments by krebskrebs for this prediction
In the thread NeuBase Therapeutics Inc. diskutieren
Buy mit Kursziel 2,5
In the thread Trading NeuBase Therapeutics Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten